TBPH
Companies
NASDAQ
Theravance Biopharma Inc.
Health Care
$10.62
+$1.21 (+12.86%)
Price Chart
Overview
About TBPH
theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.
Market Cap
$426.5M
Volume
2.5M
Avg. Volume
2.8M
P/E Ratio
138.66667
Dividend Yield
0.00%
Employees
184.0
Company Information
Latest News for TBPH
Risk & Correlation Analysis
Market Correlation
0.84
Moderate Correlation
Volatility
High (0.41)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TBPH shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$426.5M
Volume2.5M
P/E Ratio138.67
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 4, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025